| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $728.7M | -2.0% |
| Cost of Revenue | $224.9M | -6.9% |
| Gross Profit | $503.8M | +0.3% |
| R&D Expense | $136.2M | -6.8% |
| SG&A Expense | $112.2M | +1.4% |
| Operating Income | -$27.6M | +58.4% |
| Pre-tax Income | -$64.0M | +9.1% |
| Income Tax | $3.6M | +29.7% |
| Net Income | -$67.6M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $116.3M | +4.4% |
| Short-term Investments | $1.0M | -96.0% |
| Accounts Receivable | $59.0M | -5.3% |
| Current Assets | $247.8M | -9.3% |
| Total Assets | $756.0M | -10.2% |
| Current Liabilities | $172.6M | -24.9% |
| Total Liabilities | $654.0M | -11.8% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $79.0M | +61.9% |
| Capital Expenditures | $2.6M | -11.4% |
| Investing Cash Flow | $8.5M | +41.3% |
| Financing Cash Flow | -$83.4M | -120.8% |
| Free Cash Flow | $76.3M | +66.7% |
| +7.6% |
| EPS (Basic) | -$0.56 | +11.1% |
| EPS (Diluted) | -$0.56 | +11.1% |
| Stockholders' Equity |
| $102.0M |
| +2.1% |